Answers are grounded in this paper and cite their sources.
Methadone, a synthetic long-acting opioid, is commonly used in maintenance therapy for opioid addiction. Naloxone is the standard treatment for methadone overdose, capable of reversing opioid effects in both the central and peripheral nervous systems. Continuous naloxone infusion may be required to prevent re-sedation after initial treatment. Given the challenges associated with intravenous administration, alternative delivery methods are under investigation. We aimed to compare the effectiveness of intramuscular (IM) naloxone with intravenous (IV) naloxone in opioid-dependent patients with methadone overdose. A randomized clinical trial was conducted at a tertiary hospital in Tehran, Iran, involving patients with methadone overdose aged 19–59. Patients received either IM or IV naloxone following basic life support and an initial naloxone bolus. In the IV group, approximately two-thirds of the initial effective dose was administered hourly. In the IM group, the dose was adjusted every 4 h based on the calculated hourly requirement: 0.4 mg, 0.8 mg, 1.2 mg, or 1.6 mg, corresponding to calculated needs of < 0.2 mg/h, 0.2–0.4 mg/h, 0.4–0.6 mg/h, or > 0.6 mg/h, respectively. The primary outcome was the occurrence of withdrawal syndrome, assessed using COWS criteria. Naloxone dosing adjustments were guided by venous blood gas analysis and level of consciousness. Treatment response and episodes of apnea were monitored during hospitalization. A total of 160 patients with suspected methadone overdose, randomly assigned to IM or IV naloxone. Normalization of respiratory rate and level of consciousness was comparable between the IM (50.8%) and IV (49.2%) groups ( P > 0.05). COWS scores were significantly higher in the IV group. However, apnea occurred in 20 (25%) cases in the IM group and 18 (22.5%) cases in the IV group during hospitalization, each requiring a single rescue dose of naloxone. IM naloxone resulted in a significantly lower median [IQR] pulse rate (76 [70, 80] vs. 98 [88, 110] in the IV group) at four hours post-intervention. Oxygen saturation and pCO 2 levels post-naloxone were similar between the two groups. IM naloxone was associated with less severe opioid withdrawal, reflected by lower COWS scores and may represent a reasonable alternative to intravenous naloxone in selected clinical settings. However, these findings should be interpreted with caution because of the single-center design, potential variability in naloxone dosing, concomitant substance use, and the lack of confirmatory toxicological testing. Trial registration: IRCT20120629010133N6. Registered 01 January 2023.
No takes yet. Share an insight, caveat, or question.
Jangjou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: